HBK Investments’s Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CND.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-22,931
Closed -$27K 752
2022
Q1
$27K Sell
22,931
-1,013
-4% -$1.57K ﹤0.01% 607
2021
Q4
$64K Buy
+23,944
New +$61.8K ﹤0.01% 607

Other funds holding CND.WS

HBK Investments's CND.WS Position: Q2 2022 in Review

HBK Investments sold out of Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CND.WS) in Q2 2022, closing a stake of 22,931 shares — an estimated $27K sold.

HBK Investments first reported a position in CND.WS in Q4 2021 and held it in 2 quarters. The position peaked at $64K in Q4 2021. 19 funds tracked by Wall St. Rank hold CND.WS as of Q2 2022.

  • HBK Investments reported no remaining Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 22,931 Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q2 2022, an estimated $27K.
  • HBK Investments first reported a position in Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
  • HBK Investments's Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $64K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.